FDA Inspection
Piedmont Columbus Regional MidtownPiedmont Columbus Regional Midtown – FDA Inspection, Jul 11, 2024
Record Details
This FDA Inspection record concerns Piedmont Columbus Regional Midtown, with an inspection on July 11, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 94385774-4d5b-4601-9efa-ae9e5a4d975c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1243509
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Piedmont Columbus Regional Midtown
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 4, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 25, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Piedmont Columbus Regional Midtown
- FDA Inspection 1328606 - 2026-07-16
- FDA Inspection 1096339 - 2019-06-04
- FDA Inspection 970689 - 2016-05-18
- FDA Inspection 868637 - 2014-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.